AIM Vaccine Co., Ltd. Class H had a revenue of 747.85M in the quarter ending Dec 31, 2024, with 39.22%. This bring the company's revenue in the last twelve months to 1.29B, Decreased 8.52%. In the fiscal year ending Dec 31, 2024, AIM Vaccine Co., Ltd. Class H had annual revenue of 1.29B with 8.22% growth.